Log In
Print
BCIQ
Print
Print this Print this
 

Folcepri, etarfolatide (EC20)

  Manage Alerts
Collapse Summary General Information
Company Endocyte Inc.
DescriptionFolate-targeted radiopharmaceutical imaging agent
Molecular Target Folate receptor
Mechanism of ActionDiagnostic; Imaging agent
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentRegistration
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify patients most likely to benefit from folate receptor-targeted therapy
Regulatory Designation

EU - Orphan Drug (Identify patients most likely to benefit from folate receptor-targeted therapy);
EU - Standard Review (Identify patients most likely to benefit from folate receptor-targeted therapy)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today